# Mylan Teoranta - Inspection Records

Source: https://www.keypedia.com/companies/mylan-teoranta/070856c0-ee70-4d73-a354-2afd7aa24c14

> Inspection records and compliance data for Mylan Teoranta in Inverin, None. Access full analysis and detailed observations.

---

## Details

- Name: Mylan Teoranta
- FEI Number: 3002806521
- City: Inverin
- State: None
- Country Name: Ireland
- Address Line 1: Kilroe East, Inverin
- Zip Code: None
- Business Operations: API/FDF ANALYTICAL TESTING, FDF MANUFACTURE, PACK

## Related Documents

- [FDA Inspection 1202025 - Mylan Teoranta - 2022-07-15](https://www.keypedia.com/records/fda_inspections/mylan-teoranta/6e5b7570-1684-4dfc-8a51-bbff43a76d9a) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 15, 2022
- [FDA Inspection 1123541 - Mylan Teoranta - 2018-06-22](https://www.keypedia.com/records/fda_inspections/mylan-teoranta/3d250270-e334-47c2-a8e4-2f226e5893fd) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 22, 2018
- [FDA Inspection 1041657 - Mylan Teoranta - 2018-02-16](https://www.keypedia.com/records/fda_inspections/mylan-teoranta/af6aed52-4b5e-4a40-8994-3c57e1737204) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 16, 2018
- [FDA Inspection 978312 - Mylan Teoranta - 2016-06-15](https://www.keypedia.com/records/fda_inspections/mylan-teoranta/a422fcb0-86db-493a-99fd-3d388f1b379e) — classification: No Action Indicated (NAI), source: FDA, date: June 15, 2016
- [FDA Inspection 886146 - Mylan Teoranta - 2014-05-27](https://www.keypedia.com/records/fda_inspections/mylan-teoranta/b043bac6-5e98-4334-9237-2d1fd03c5f93) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 27, 2014
- [FDA Inspection 782346 - Mylan Teoranta - 2012-03-30](https://www.keypedia.com/records/fda_inspections/mylan-teoranta/40d105d9-d8fe-4082-88ec-cd955e4f7047) — classification: No Action Indicated (NAI), source: FDA, date: March 30, 2012
- [FDA Inspection 628714 - Mylan Teoranta - 2009-10-15](https://www.keypedia.com/records/fda_inspections/mylan-teoranta/459ffe9f-4393-418d-a994-19c095ed4df0) — classification: No Action Indicated (NAI), source: FDA, date: October 15, 2009

## Related Companies

- [Combe Laboratories, Inc.](https://www.keypedia.com/companies/combe-laboratories-inc/165d44db-fdc0-4975-af22-35ec39c2735d)
- [Orion Corporation, Orion Pharma](https://www.keypedia.com/companies/orion-corporation-orion-pharma/bc21b600-e8f7-4570-9285-d3c41399fd82)
- [Penn Pharmaceutical Services Limited](https://www.keypedia.com/companies/penn-pharmaceutical-services-limited/0568bf3c-6deb-4f8f-9174-a7ff34c80343)
- [Haleon US Holdings LLC](https://www.keypedia.com/companies/haleon-us-holdings-llc/03c10541-23fe-4547-ae02-c47669f35343)
- [Delpharm Huningue S.A.S.](https://www.keypedia.com/companies/delpharm-huningue-sas/abe67002-072d-48fc-8ace-21b8021482f7)
- [Haupt Pharma Wuelfing GmbH](https://www.keypedia.com/companies/haupt-pharma-wuelfing-gmbh/34339ef4-fb2f-4297-ae5d-191a6adb86b0)
- [Orion Corporation, Orion Pharma](https://www.keypedia.com/companies/orion-corporation-orion-pharma/afdfe2db-9213-4d8d-84c3-4627195bb4c7)
- [GlaxoSmithKline LLC](https://www.keypedia.com/companies/glaxosmithkline-llc/66fdfcfe-6173-4e09-abb4-df089ede2996)
- [P & L Development LLC](https://www.keypedia.com/companies/p-l-development-llc/eed180a2-666b-448a-a387-2ddc3e1e9d91)
- [S.s.s. Company (international)](https://www.keypedia.com/companies/sss-company-international/f322f704-186a-434c-83d2-9468fed1ae6e)